Soleno Therapeutics, Inc. · NASDAQ:SLNO

Anish Bhatnagar disposed of 583,656 Soleno Therapeutics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 18, 2026

On May 18, 2026, Anish Bhatnagar (Director, CHIEF EXECUTIVE OFFICER) disposed of 583,656 Soleno Therapeutics, Inc. shares, leaving 0 shares. Filed May 18, 2026 (Form 4).

Disposed of
583,656 shares
Holding after
0 shares
Trading plan
No
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockDisposition583,6560Direct

Source

View original at SEC

Related